CLX:NYE-The Clorox Company (USD)

COMMON STOCK | Household & Personal Products | NYE

Last Closing Price

USD 183.01

Change

0.00 (0.00)%

Market Cap

USD 22.76B

Volume

0.98M

Average Target Price

USD 205.24 (+12.14%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands. It also provides grilling products under the Kingsford and Match Light brands; bags and wraps under the Glad brand; and cat litter products under the Fresh Step, Scoop Away, and Ever Clean brands. In addition, the company offers dressings and sauces primarily under the Hidden Valley brand; water-filtration systems and filters under the Brita brand; and natural personal care products under the Burt's Bees brand. Further, it markets its products under the Ayudin, Clorinda, and Poett brands. The company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. Clorox has a collaboration partnership with Cleveland Clinic and the CDC Foundation. The Clorox Company was founded in 1913 and is headquartered in Oakland, California.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-09 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
PG The Procter & Gamble Company

N/A

USD330.88B 24.85 16.63
UN Unilever PLC

N/A

USD158.84B 23.94 16.70
UL Unilever PLC

N/A

USD156.01B 23.46 16.85
EL The Estée Lauder Companies In..

N/A

USD109.97B 80.32 43.60
CL Colgate-Palmolive Company

N/A

USD69.52B 26.42 17.26
KMB Kimberly-Clark Corporation

N/A

USD45.72B 20.32 14.18
CHD Church & Dwight Co., Inc

N/A

USD21.44B 28.39 19.32
COTY Coty Inc

N/A

USD7.93B 232.30 N/A
SPB Spectrum Brands Holdings, Inc

N/A

USD4.04B 20.13 10.67
NUS Nu Skin Enterprises, Inc

N/A

USD2.96B 14.00 9.32

ETFs Containing CLX

Symbol Name Weight Mer Price(Change) Market Cap
FHC:CA First Trust Dow Jones Int.. 0.00 % 0.77 %

N/A

USD2.57M
USMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.65 %

N/A

N/A
UBUR:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.25 %

N/A

USD0.09B
OSX2:XETRA Ossiam US Minimum Varianc.. 0.00 % 0.65 %

N/A

N/A
UBUV:F UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

N/A

USD0.01B
UBUR:F UBS (Irl) ETF plc - Facto.. 0.00 % 0.25 %

N/A

USD0.09B
OSX2:F Ossiam Lux - Ossiam US Mi.. 0.00 % 0.65 %

N/A

N/A
SPMV:PA Ossiam US Minimum Varianc.. 0.00 % 0.65 %

N/A

N/A
MVUS:PA Ossiam US Minimum Varianc.. 0.00 % 0.65 %

N/A

N/A
XDWE:LSE Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

N/A

USD5.94B
USLV:LSE SPDR S&P 500 Low Vola.. 0.00 % 0.35 %

N/A

USD0.26B
MUS:CA Mackenzie Maximum Diversi.. 0.00 % 0.45 %

N/A

USD0.17B
LUMV:LSE Ossiam US Minimum Varianc.. 0.00 % 0.65 %

N/A

USD0.08B
LOWV:LSE SPDR S&P 500 Low Volatili.. 0.00 % 0.35 %

N/A

USD0.23B
FHC-F:CA First Trust Dow Jones Int.. 0.00 % 0.00 %

N/A

N/A
RWU-B:CA CI MSCI USA Low Risk Weig.. 0.00 % 0.60 %

N/A

N/A
RBUS Nationwide Risk-Based U.S.. 0.00 % 0.30 %

N/A

USD0.12B
MXDU Nationwide Maximum Divers.. 0.00 % 0.34 %

N/A

USD0.11B
BVAL Brand Value ETF 0.00 % 0.65 %

N/A

USD9.33M
SCIU Global X Scientific Beta .. 0.00 % 0.19 %

N/A

USD0.02B
RWU:CA CI MSCI USA Low Risk Weig.. 0.00 % 0.60 %

N/A

USD0.01B
UBUV:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.35 %

N/A

USD0.01B

Market Performance

  Market Performance vs.
Industry/Classification (Household & Personal Products)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.37% 7% F 9% F
Dividend Return 1.10% 73% C 53% F
Total Return -8.27% 7% F 9% F
Trailing 12 Months  
Capital Gain -10.31% 13% F 5% F
Dividend Return 2.18% 36% F 32% F
Total Return -8.14% 13% F 5% F
Trailing 5 Years  
Capital Gain 37.77% 69% D+ 53% F
Dividend Return 14.45% 60% D- 49% F
Total Return 52.22% 69% D+ 52% F
Average Annual (5 Year Horizon)  
Capital Gain 13.65% 80% B- 78% C+
Dividend Return 2.68% 50% F 61% D-
Total Return 16.33% 67% D+ 79% C+
Risk Return Profile  
Volatility (Standard Deviation) 15.49% 73% C 66% D
Risk Adjusted Return 105.40% 80% B- 93% A
Market Capitalization 22.76B 69% D+ 89% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Household & Personal Products)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 25.43 53% F 32% F
Price/Book Ratio 30.82 20% F 3% F
Price / Cash Flow Ratio 14.72 56% F 33% F
EV/EBITDA 17.08 43% F 41% F
Management Effectiveness  
Return on Equity 113.78% 87% B+ 99% A+
Return on Invested Capital 29.29% 81% B- 95% A
Return on Assets 15.35% 88% B+ 98% A+
Debt to Equity Ratio 306.17% 21% F 10% F
Technical Ratios  
Short Ratio 6.38 19% F 9% F
Short Percent 8.15% 21% F 36% F
Beta 0.18 93% A 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector